Atossa Therapeutics (ATOS) Tax Provisions (2020 - 2025)
Atossa Therapeutics (ATOS) posted quarterly Tax Provisions of -$5.4 million for Q4 2024, down 23.78% quarter-over-quarter from -$4.3 million in Q4 2021.
Atossa Therapeutics (ATOS) Tax Provisions (2020 - 2025) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Tax Provisions for 3 consecutive years, with -$5.4 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Tax Provisions changed N/A year-over-year to -$5.4 million; the TTM figure through Sep 2025 stood at -$5.4 million (changed N/A YoY), while the FY2024 annual figure was -$5.4 million, changed N/A from the prior year.
- Tax Provisions slipped to -$5.4 million in Q4 2024 per ATOS's latest filing, from -$4.3 million in the prior quarter.
- Across five years, Tax Provisions topped out at -$3.7 million in Q4 2020 and bottomed at -$5.4 million in Q4 2024.
- Historically, Tax Provisions has averaged -$4.5 million across 3 years, with a median of -$4.3 million in 2021.
- On a YoY basis, Tax Provisions climbed as much as 15.57% in 2021 and fell as far as 15.57% in 2021.
- Atossa Therapeutics' Tax Provisions stood at -$3.7 million in 2020, then decreased by 15.57% to -$4.3 million in 2021, then retreated by 23.78% to -$5.4 million in 2024.
- Business Quant data shows ATOS's Tax Provisions at -$5.4 million in Q4 2024, -$4.3 million in Q4 2021, and -$3.7 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.30 Mn |
| Dec 31, 2024 | -5.36 Mn |
| Dec 31, 2021 | -4.33 Mn |
| Dec 31, 2020 | -3.74 Mn |